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Background: The mechanism regarding rapid progression of residual hepatocellular carcinoma (HCC) after
insufficient radiofrequency ablation (RFA) has been preliminarily discussed. However, most studies have mainly
focused on RFA-induced changes in the tumor cells. The present study was designed to determine whether tumor-
associated endothelial cells (TAECs) could contribute to the invasiveness of HCC after insufficient RFA.
Methods: TAECs were isolated from fresh HCC tissue and characterized. Morphological changes were observed in
TAECs after heat treatment for 10 min. TAEC proliferation, migration and tube formation after heat treatment for 10
min at 37°C (control group), and 42 and 47°C (insufficient RFA groups) were examined. The differences in TAECs
interactions with HepG2-GFP or HCCLM3-GFP cells among the two insufficient RFA groups and control group were
evaluated. The expression of E-selectin, ICAM-1 and VCAM-1 in TAECs was measured. The effects of TAECs on the
invasiveness of HepG2-GFP or HCCLM3-GFP cells after insufficient RFA were analyzed. The IL-6, IL-8, MCP-1 and
GRO-α concentrations in conditioned medium from TAECs were measured after insufficient RFA. The associated
signaling pathways of Akt, ERK1/2, STAT3 and NF-κB were analyzed in TAECs after insufficient RFA.
Results: TAECs expressed the EC-specific markers and took up complexes of Dil-Ac-LDL. Relative to the control
group, the proliferation of TAECs was significantly inhibited and their migration and tube formation were
significantly enhanced in the insufficient RFA groups. Significantly more HepG2-GFP or HCCLM3-GFP cells adhered
to TACEs in these groups than in the control group (all P<0.001), via up-regulated expression of E-selectin, ICAM-1
and VCAM-1. TAECs promoted the invasiveness of HepG2-GFP or HCCLM3-GFP cells after insufficient RFA via the
up-regulation of IL-6, IL-8, MCP-1 and GRO-α in conditioned medium (all P<0.05). Insufficient RFA enhanced the
activities of Akt, ERK1/2 and NF-κB signaling pathways and inhibited STAT3 signaling pathways.
Conclusions: Insufficient RFA enhanced TAEC migration and tube formation, and this may play a key role in the
rapid growth of residual HCC. Increased expression of metastasis-related molecules in TAECs after insufficient RFA
may be a potential mechanism for the metastasis of residual HCC.
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Hepatocellular carcinoma (HCC) is the sixth most com-
mon neoplasm and the third most frequent cause of
cancer death [1]. Most HCC patients have underlying
cirrhosis, which complicates the management of their
cancer, especially in the case of early HCC in the setting
of well-compensated cirrhosis [2]. Recently, radiofre-
quency ablation (RFA) has been considered as being po-
tentially curative for early-stage HCC in patients with or
without surgical prospects owing to its ease of use, safety
and cost-effectiveness, and the fact that it is minimally
invasive [3]. However, one of the major problems with
RFA is the difficulty in achieving complete tumor de-
struction [4]. Because of the heat sink effect of blood
vessels or the fact that the periphery of the tumor is dis-
tant from the center of ablation, the target temperature
for ablation can not be easily achieved throughout the
tumor; consequently, residual HCC can be present after
RFA [5].
In the past decade, rapid tumor progression and sar-
comatous changes after RFA have been reported in in-
creasing numbers of clinical centers [6-8]. In particular,
rapid tumor progression after RFA, which may mostly
be associated with the progression of residual HCC, has
been gaining increasing attention, and several underlying
mechanisms for this phenomenon have been proposed.
Our previous studies have demonstrated that insufficient
RFA could facilitate rapid progression in residual hepatic
VX2 carcinoma due to the induction of the over-
expression of several molecular factors, and also pro-
moted angiogenesis in residual HCC via hypoxia-
inducible factor-1α (HIF-1α)/vascular endothelial growth
factor-A (VEGFA) [9,10]. Another study also showed
that insufficient RFA therapy may induce further malig-
nant transformation of HCC [11]. However, these studies
have mainly been focused on RFA-induced changes to
the tumor cells. Whether or not non-tumor cells are also
affected by insufficient RFA, and consequently contrib-
ute to progression of tumor cells, is still poorly
understood.
In primary tumors, cancer cells are surrounded by a
complex microenvironment comprised of numerous
cells including endothelial cells present in the blood and
lymphatic circulation, stromal fibroblasts and a variety
of bone marrow-derived cells [12]. Evidence is accumu-
lating that the altered microenvironment after RFA may
enhance the outgrowth of residual tumor cells [4,13-15].
Tumor-associated endothelial cells (TAECs), as an im-
portant component of the microenvironment of tumor,
play a key role in angiogenesis. This is crucial for the
growth and invasion of solid tumors, as the vasculature
provides metabolic support for tumor cells and serves as
the gatekeeper for their escape and entry into the circu-
lation [16]. What is more, evidence also shows thatTAECs express tumor-specific endothelial markers and
contain several regulated secretory organelles. These in-
clude Weibel-Palade bodies, the tissue plasminogen
activator (tPA) organelle, and the type-2 chemokine-
containing organelle, which are responsible for the
secretion of tPA, cytokines IL-8 and IL-6, monocyte
chemoattractant protein-1 (MCP-1), and growth-regulated
oncogene-α (GRO-α) [17-19]. It has yet to be established
if insufficient RFA enhances angiogenesis in TAECs.
Whether or not TAECs promote the invasiveness of
residual HCC via secreted cytokines and help residual
tumor cells intravasate into the circulation after insuf-
ficient RFA also requires further investigation.
In the present study, we explored the biological behav-
ioral changes in TAECs after insufficient RFA, and
whether or not insufficient RFA promoted the metastasis
of hepatoma cells via the enhanced secretion of cyto-
kines and expression of adhesion molecules in TAECs.
Materials and methods
Patients
Fresh HCC tissues were obtained from seven patients
who had positive α-fetoprotein (AFP) with curative liver
resection at the Liver Cancer Institute and Zhongshan
Hospital, Fudan University (Shanghai, China). The study
design was approved by the Ethics Committee of Fudan
University, and all the study participants provided
informed consent.
Cell lines and cell culture
Stable green fluorescent protein (GFP)-expressing
HepG2 and HCCLM3 cells, two human HCC cell lines
established at the Liver Cancer Institute and Zhongshan
Hospital [20,21], were maintained in high-glucose
DMEM (Gibco, Los Angeles, USA) supplemented with
10% fetal bovine serum (FBS; Gibco, Los Angeles, USA),
100 U/ml penicillin and 100 μg/ml streptomycin in a hu-
midified atmosphere of 5% CO2 at 37°C. TAECs were
isolated as described before [22]. Briefly, TAECs were
obtained from surgical HCC specimens immediately
after removal from patients. Specimens were minced
and digested by incubation for 1 h at 37°C in 1640
medium (Gibco, Los Angeles, USA) containing 0.1% col-
lagenase IV (Sigma-Aldrich, St. Louis, MO, USA). After
washing in PBS (Gibco, Los Angeles, USA), the cell sus-
pension was forced through a graded series of meshes to
separate the cell components from stroma and aggre-
gates. TAECs were isolated from cell suspension using
anti-CD31 monoclonal antibodies (mAbs) coupled to
magnetic beads (Miltenyi Biotech, Bergisch Gladbach,
Germany) and magnetic cell-sorting using the MACS
system (Miltenyi Biotech, Bergisch Gladbach, Germany).
To increase the purity of isolated TAECs after positive
magnetic bead isolation, the cell pellets underwent a
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in complete EGM-2 medium (Lonza, Basel, Switzerland)
supplemented with 10% FBS, 100 U/ml penicillin and
100 μg/ml streptomycin in a humidified atmosphere of
5% CO2 at 37°C. TAECs were used at passages 1–6.
Immunofluorescence analysis
TAECs were grown on 24-well plates to 40-50% conflu-
ence, then fixed and blocked. Cells were then incubated
with primary monoclonal or polyclonal antibodies against
CD31, CD34, vascular endothelial growth factor receptor-1
(VEGFR1), vascular endothelial growth factor receptor-2
(VEGFR2), von Willebrand factor (vWF), CD68 and
αSMA (Santa Cruz, California, USA) overnight at 4°C. The
next day, plates were washed and incubated with anti-
mouse or anti-rabbit fluorescein isothiocyanate- and/or
tetramethyl rhodamine isothiocyanate-conjugated secondary
antibody (Invitrogen, Carlsbad, USA). Cells were coun-
terstained with 4'-6-diamidino-2-phenylindole (DAPI;
KeyGen Biotech, Nanjing, China) to visualize cell nuclei
and observed using an inverted fluorescence microscopy
(Olympus IX51) equipped with an Olympus Qcolor 3
digital camera (Olympus).
Internalization of acetylated low-density lipoprotein
TAECs were incubated in serum-free EBM-2 medium
containing 10 μg/ml rhodamine-labeled 1,1V-dioctadecyl-
3,3,3V,3V-tetramethylindocarbocyanine acetylated low-
density lipoprotein (Dil-Ac-LDL; Sigma-Aldrich, St. Louis,
MO, USA) for 4 h at 37°C. The cells were fixed in
4% paraformaldehyde for 20 min at room temperature.
Cells were counterstained with DAPI to visualize cell
nuclei and analyzed using an inverted fluorescence
microscope (Olympus IX51) equipped with an Olympus
Qcolor 3 digital camera (Olympus).
Heat treatment
TAECs were seeded onto the 6-cm dishes, and after
24-h incubation they were exposed to heat treatment.
Heat treatment was carried out by sealing the tops of
culture plates with parafilm, and submerging the plates
in a water bath set to the desired temperature for 10
min. We selected heat treatments of 42 and 47°C for 10
min to simulate the effects of insufficient RFA and 37°C
for 10 min as the control treatment in vitro. Cell mor-
phological changes were observed using an inverted
fluorescence microscope (Olympus IX51) equipped with
an Olympus Qcolor 3 digital camera (Olympus).
TAEC proliferation, migration and tube formation after
heat treatment
TAEC proliferation was measured using a Cell Counting
Kit-8 (CCK-8; Dojindo, Kumamoto, Japan) according to
the manufacturer's instructions. Briefly, TAECs werecultured in 96-well plates at a concentration of 3 × 103/
well. After 24-h incubation, the plates were heat treated
for 10 min at 37, 42 or 47°C. After incubation for 24, 48
or 72 h, 5 μL of CCK-8 reagent was added to each well.
The absorbance was measured at 450 nm after 2.5-h
incubation at 37°C.
TAECs were plated into the 6-well plates, and after
24-h incubation the plates were sealed and submerged
for 10 min in a water bath set to 37, 42 or 47°C. At 24,
48 or 72 h after heat treatment, TAECs were trypsinized
and resuspended for further experiments involving mi-
gration and tube formation.
Quantitative cell migration assays were performed
using a modified Boyden chamber (Costar-Corning, New
York, USA) with 8.0-μm pore polycarbonate filter inserts
in 24-well plates as described previously [9]. Briefly, the
lower chamber was filled with EGM-2 with 10% FBS,
and TAECs (5 × 104 cells/well) in serum-free medium
were added into the upper chamber. The cells were
allowed to migrate for 5 h at 37°C. The non-migrated
cells were removed from the upper surface of the mem-
brane by scraping with a cotton swab, and the migrating
cells were fixed with methanol, stained with crystal violet
(Beyotime, Nantong, China) and photographed under an
inverted fluorescence microscope (Olympus IX51)
equipped with an Olympus Qcolor 3 digital camera
(Olympus). Migration was assessed by counting the
number of stained cells from 10 random fields at ×100
magnification.
TAECs tube formation was studied on growth factor-
reduced Matrigel (Becton Dickinson, San Jose, USA)
diluted 1:1 in ice with cold EBM-2 in a 96-well plate.
Cells (1 × 104 cells/well) were added to Matrigel-coated
96-well plates. TAECs were photographed under an
inverted fluorescence microscope (Olympus IX51)
equipped with an Olympus Qcolor 3 digital camera
(Olympus). Tube formation was assessed by counting
the number of loops from 10 random fields at ×50
magnification.
Collection of the conditioned medium and cell protein
TAECs were cultured in a T25 culture bottle at a con-
centration of 5 × 105 cells in EGM-2 containing 10%
FBS. After 24-h incubation, 1 ml of fresh EBM-2 was
added to the culture bottle with replacement of EGM-2.
The culture bottles were submerged in a water bath for
10 min at 37, 42 or 47°C. Immediately after heat treat-
ment, 2 ml of fresh EBM-2 was added to each culture
bottle and cells were cultured in the incubator at 37°C.
After 24-h incubation, the medium was collected and
spun down at 3000 rpm for 20 min, and the supernatant
was collected and stored at −80°C. Cells were lysed using
cell lysis buffer (150 mM NaCl; 50 mM Tris–HCl; pH
8.0; 0.1% SDS; and 1% Triton X-100) containing
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for further experiments.
Matrigel invasion assay
The invasiveness of hepatoma cells was assessed by meas-
uring their ability to invade through Matrigel-coated
transwell inserts with 8.0-μm pores (Costar-Corning, New
York, USA). HepG2-GFP or HCCLM3-GFP cells were
trypsinized and resuspended with conditioned medium.
200 μl of cell suspension (2 × 104 or 5 × 104 cells) was
added to each upper well, and the lower chamber was
filled with DMEM with 10% FBS. Hepatoma cells were
allowed to invade for 36 h at 37°C. The non-invaded cells
were removed from the upper surface of the membrane
by scraping with a cotton swab, and the invaded cells
were fixed with methanol, stained with crystal violet, and
photographed under inverted fluorescence microscopy
(Olympus IX51) equipped with an Olympus Qcolor 3
digital camera (Olympus). Invasion was assessed by
counting the number of stained cells from 10 random
fields at ×100 magnification.
Enzyme-linked immunosorbent assay
Cytokines secreted into the conditioned medium were
quantified using an enzyme-linked immunosorbent assay
(ELISA) kits (for IL-6, MCP-1, IL-8 and GRO-α; Boster,
Wuhan, China) according to the manufacturer’s instruc-
tions. The concentration of cytokines was normalized to
the total cellular protein.
Western blot
Equivalent amounts of whole cell extracts were sub-
jected to SDS-PAGE gel and transferred to nitrocellulose
membranes. The membranes were blocked with 5%
non-fat milk for 2 h and then incubated with respective
primary antibody overnight at 4°C followed by the incu-
bation with the appropriate HRP-conjugated secondary
antibody for 1.5 h at room temperature. Blots were
visualized with an ECL detection kit (Pierce, USA) and
analyzed using Quantity One 1-D Analysis Software
(Bio-Rad, Hercules, USA).
TAEC-tumor cell adhesion assay
TAECs were plated onto 96-well plates and allowed to
grow until complete confluence was achieved. The plates
were submerged in a water bath for 10 min at 37, 42 or
47°C. After 24-, 48- or 72-h incubation, cells were rinsed
with PBS twice, and HepG2-GFP or HCCLM3-GFP cells
(1 × 104 cells) in fresh DMEM were added to the wells.
The plates were incubated at 37°C in 5% CO2 for 20
min. Non attached cells were removed by washing thrice
with PBS and the attached hepatoma cells in each well
were visualized under a microscope and counted using
an inverted fluorescence microscope (Olympus IX51)equipped with an Olympus Qcolor 3 digital camera
(Olympus).
Cell surface adhesion molecules assay using cell ELISA
TAECs were plated onto 96-well plates and allowed to
grow until 80% confluence. The plates were submerged
in a water bath for 10 min at 37, 42 or 47°C. After 24-,
48- or 72-h incubation, cells were washed with PBS
twice and fixed with PBS containing 4% paraformalde-
hyde at room temperature. The plates were blocked with
2% BSA at 37°C for 2 h. Cell surface expressions of ad-
hesion molecules were determined by means of primary
binding with specific antibody for VCAM-1, ICAM-1 or
E-selectin (Santa Cruz, California, USA), followed by
secondary binding with an HRP-conjugated goat anti-
rabbit IgG antibody. Quantification was performed by
determination of colorimetric conversion at OD at 450
nm of 3,3’,5,5’-tetramethylbenzidine using a TMB perox-
idase EIA substrate kit (Bio-Rad, Hercules, USA).
Statistical analysis
Student’s t test or the ANOVA test was used for
comparison of two groups or three groups using
GraphPad Prism (GraphPad Software Inc., La Jolla,
CA). A P value of <0.05 was set as the level of statis-
tical significance.
Results
Isolation and characterization of TAECs from tumor tissue
Seven strains of CD31+ TAECs were obtained from
seven HCC patients. In addition to CD31, TAECs virtu-
ally expressed the EC-specific markers vWF, VEGFR1,
VEGFR2 and CD34 (Figure 1A). Negative expression of
CD68 and α-SMA in isolated TAECs excluded the con-
tamination of macrophages and fibroblasts (Figure 1A).
Western blot confirmed the immunofluorescence results
and that AFP expression could be detected in tumor
cells but not in TAECs (Figure 1B). TAECs also took up
complexes of Dil-Ac-LDL (Figure 1C).
The effect of heat treatment on TAECs
In order to simulate the growth pattern of TAECs that
were not killed after the heat stress generated by RFA,
TAECs were exposed to a 10-min heat treatment at
temperatures ranging from 37 to 55°C, and after 36 h,
morphological changes in TAECs were observed. It was
found that TAECs could not be continuously cultured
once the temperature exceeded 47°C (Figure 2A). To
monitor the potential effect of insufficient RFA on the
function of TAECs in vitro, we initially observed the
cell proliferation, migration and tube formation of
TAECs at 24, 48 and 72 h after heat treatment. It
was found that the proliferation of TAECs after insuf-
ficient RFA was significantly decreased as compared
Figure 1 Verification of TAECs from HCC. (A) Representative immunofluorescence analysis of TAECs showing positive expression of the
endothelial markers CD31, CD34, VEGFR1, VEGFR2 and vWF, and negative expression of the macrophages and fibroblast markers CD68 and
α-SMA. (B) Western blot analysis used to verify the immunofluorescence results and assess the purity of the isolated CD31+ TAECs. (C)
Micrograph representative of the uptake of Dil-Ac-LDL in TAECs. Five TAECs preparations were analyzed with similar results.
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was interesting that the insufficient RFA treatment
promoted the migration and tube formation of TAECs;
this was not observed after the control treatment
(Figure 2C and D).Promotion of adhesion of TAECs to hepatoma cells after
insufficient RFA
HepG2-GFP or HCCLM3-GFP cells were used to inves-
tigate the adhesion ability of TAECs after insufficient
RFA. TAECs were treated with insufficient RFA or the
control treatment. After a 24-, 48- or 72-h interval,
they were incubated at 37°C and hepatoma cells were
added. The results showed that after insufficient RFA
TACEs adhered to HepG2-GFP cells at a significantly
higher level than the case after the control treatment
(all P <0.001; Figure 3A and B). Similar results were
observed in HCCLM3-GFP cells (all P <0.001;
Additional file 1: Figure S1). In order to explore the
mechanism involved in the process, we measured thesurface expressions of the TAEC adhesion molecules
after insufficient RFA using cell ELISA. The results
showed that the expression of E-selectin, intercellular
adhesion molecule (ICAM)-1 and vascular cell adhesion
molecule (VCAM)-1 were significantly up-regulated on
the surface of TAECs at 24, 48 and 72 h after insuffi-
cient RFA (Figure 3B). Western blot also confirmed the
cell ELISA results (Figure 3C).Promotion of the invasiveness of hepatoma cells by
TAECs after insufficient RFA
Using the conditioned media from TAECs with or
without insufficient RFA treatment, we further explored
the effect of TAECs on the invasiveness of hepatoma
cells. Conditioned medium from TAECs after insuffi-
cient RFA significantly enhanced the invasiveness of
HepG2-GFP cells relative to the control (Figure 4A).
Similar results were observed in HCCLM3-GFP cells
(Additional file 2: Figure S2). To test the possible
mechanism involved in the promotion of the invasiveness
Figure 2 Morphological changes in TAECs after heat treatment at different temperatures and inhibition of their proliferation and
enhancement of their migration and tube formation after insufficient RFA. (A) Representative micrograph of morphological change in
TAECs after a 10-min heat treatment at temperatures ranging from 37 to 55°C. (B) TAECs were cultured after insufficient RFA (42 or 47°C
treatment for 10 min). The proliferation of TAECs at 24, 48 and 72 h after heat treatment were measured using the CCK-8 assay. Columns: means
from three individual experiments with five samples per group; bars: SE; *: P <0.05; ns: no significance. (C) TAECs were cultured after insufficient
RFA and the migration of TAECs at 24, 48 and 72 h were measured using the trans-well assay. Representative micrographs of migration are
shown. (D) TAECs were cultured after insufficient RFA and TAEC tube formation at 24, 48 and 72 h was evaluated using the Matrigel tube
formation assay. Representative micrographs of tube formation are displayed. Data represent the representative results from three independent
experiments with five samples per group.
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measured the levels of cytokine secreted by TAECs in
the conditioned medium. We found that insufficient
RFA significantly increased the secreted levels of IL-8,
IL-6, MCP-1 and GRO-α by TAECs (all P<0.05;
Figure 4B).Enhancement of the activity of ERK1/2, NF-κB and Akt
signaling pathways and inhibition of STAT3 signaling
pathway after insufficient RFA
To further determined the associated signal pathways
involved in the process as described above, we investi-
gated the expression levels of total and phosphorylated
Figure 3 Increased TAEC interaction with tumor cells and up-regulated expression of E-selectin, ICAM-1 and VCAM-1 after insufficient
RFA. (A-B) TAECs were cultured after insufficient RFA, and HepG2-GFP cells were added after 24, 48 and 72 h. Representative micrographs of
TAECs regarding the interaction with HepG2-GFP cells are shown. Columns: means from three individual experiments with five samples per
group; bars: SE; ***: P <0.001. (C) The expression of E-selectin, ICAM-1 and VCAM-1 on the surface of TAECs after insufficient RFA was detected
using cell ELISA analysis. Columns: means from three individual experiments with five samples per group; bars: SE; *: P <0.05; **: P <0.01; ns: no
significance. (D) Expression of E-selectin, ICAM-1 and VCAM-1 in TAECs after insufficient RFA detected by western blot analysis. Data are the
representative results of three independent experiments with five samples per group.
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h after insufficient RFA. It was found that total protein
levels of ERK1/2, NF-κB, Akt and STAT3 were not chan-
ged after insufficient RFA, whereas phosphorylated
ERK1/2 (p-ERK1/2), NF-κB and p-Akt were up-
regulated and p-STAT3 was substantially down-
regulated in TAECs after insufficient RFA (Figure 5).
Discussion
RFA heats tumor tissue owing to ionic friction generated
by the radiofrequency current, which induces coagula-
tion necrosis once the tissue temperature exceeds 50°Cfor 4–6 min [23]. If the HCC tumor is not completely
coagulated, the residual tumor cells are prone to prolif-
eration, invasion and angiogenesis [9-11]. On the other
hand non-tumor cells, especially TAECs, are also
exposed to RFA, and insufficient RFA can theoretically
influence the behavior of these cells. It remains poorly
understood as to whether or not TAECs promote the
metastasis of hepatoma cells after insufficient RFA.
The growth and migration of endothelial cells are es-
sential for tumor angiogenesis [24]. In the absence of
local neovascular formation, the tumor may not grow
beyond 2–3 mm in diameter [25]. Most of the previous
Figure 4 Promotion of the invasiveness of hepatoma cells by TAECs after insufficient RFA. (A) HepG2-GFP invasion in vitro in response to
conditioned media from TAECs was assayed after the control treatment or insufficient RFA. Data are the representative results of three
independent experiments with five samples per group. (B) IL-6, IL-8, MCP-1 and GRO-α concentrations in conditioned medium were detected
using the ELISA assay. Columns: means from three individual experiments with five samples per group; bars: SE; *: P <0.05; **: P <0.01; ***:
P <0.001.
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using normal endothelial cells (NECs) such as human
umbilical vein endothelial cells. The use of NECs does
not reflect the real tumor microenvironment. In contrast
TAECs, which express tumor-specific endothelial mar-
kers, are cytogenetically abnormal and genetically un-
stable [18,19]. TAECs also manifest an increased
angiogenesis capability and drug resistance, and display
resistance to interferon γ as compared with NECs under
hypoxia [22,26]. Accordingly, the use of TAECs as a tool
to research angiogenesis virtually reflects the micro-
environment of tumor. Here, for the first time, we have
observed the effect of insufficient RFA on TAECs
in vitro. We isolated the CD31+ TAECs from fresh HCC
tissue and found that insufficient RFA enhanced the mi-
gration and tube formation of these cells, but inhibited
their proliferation. The results revealed that after insuffi-
cient RFA TAECs may enhance autochthonous angio-
genesis to promote the rapid growth of residual HCC.The reason that the proliferation of TAECs was inhibited
may be that insufficient RFA induced cell apoptosis and/
or mitotic failure over a short time period.
Metastasis results from completion of a complex suc-
cession of cell-biological events-collectively termed the
invasion-metastasis cascade. The process of cancer cell
metastasis consists of: (1) local invasion through the sur-
rounding extracellular matrix (ECM) and stromal cell
layers; (2) intravasation into the lumina of blood vessels;
(3) survival of the rigors of transport through the vascu-
lature; (4) arrest at distant organ sites; (5) extravasation
into the parenchyma of distant tissues; (6) initial survival
in these foreign microenvironments in order to form
micrometastases; and (7) reinitiation of proliferative pro-
grams at metastatic sites, thereby generating macro-
scopic, clinically detectable neoplastic growths [27].
Each of these processes involves rate-limiting steps that
are influenced by non-malignant cells in the tumor
microenvironment [12]. Previous studies have also
Figure 5 Enhanced activity of ERK1/2, NF-κB and Akt signaling
pathways and inhibition of the STAT3 signaling pathway after
insufficient RFA. The changes in signaling pathways involving
TAECs after insufficient RFA were detected using western blot. Data
are the representative results of three independent experiments
with five samples per group.
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outgrowth and metastasis of residual tumor cells. How-
ever, it has not previously been reported that a non-
malignant cell type in vitro can contribute adversely to
the altered microenvironment after insufficient RFA.
It is known that the first step in metastasis is local in-
vasion of hepatoma cells through the surrounding ECM.
In present study, we found that TAECs significantly pro-
moted hepatoma cells cell invasion through Matrigel
in vitro after insufficient RFA. This suggested that cyto-
kines secreted by TAECs in conditioned medium after
insufficient RFA led to the increased invasiveness of the
hepatoma cells. TAECs can secrete many cytokines, for
example IL-8, IL-6, MCP-1 and GRO-α [17]. IL-8 plays
an important role in inflammation, tumor-induced
angiogenesis and tumor metastasis and IL-6 is involved
in the proliferation, differentiation and metastasis of
various malignant tumor cells [28-30]. MCP-1 secreted
by hepatic myofibroblasts promotes the migration and
invasion of human hepatoma cells, and MCP-1 sup-
presses the inhibition of tumor growth and metastasis in
lung cancer and HCC [31-33]. High serum levels of IL-
6, IL-8 and MCP-1 have been shown to be positively
correlated with tumor development in cancer patients
[34-36]. GRO-α plays an important role with regard to
disease progression and metastasis formation and has
also been demonstrated to be positively associated with
tumor size, stage, invasion, lymph node metastasis and
patient survival in colorectal cancers [37,38]. In thepresent study, we discovered that cytokines secreted by
TAECs including IL-6, IL-8, MCP-1 and GRO-α were
up-regulated after insufficient RFA, which may explain
the enhanced invasiveness ability of hepatoma cells.
The second step in metastasis involves the intravasa-
tion of hepatoma cells into the lumens of blood vessels,
and the interaction of hepatoma cells with TAECs plays
an important role in the process. In our study we
observed that after insufficient RFA TACEs adhered to
significantly more hepatoma cells. Meanwhile E-selectin,
ICAM-1 and VCAM-1, which are all expressed on vas-
cular endothelial cells, have been found to be responsible
for the formation of firm adhesion between the tumor
and the endothelium [39-42]. Our results revealed that
insufficient RFA up-regulated the expression of E-selec-
tin, ICAM-1 and VCAM-1 in TAECs, which suggests
that up-regulated adhesion molecules may be the mech-
anism responsible for the enhanced adhesion of TAECs
to hepatoma cells.
The biological changes in TAECs after insufficient
RFA must involve various cell signal pathways. Activa-
tion of Akt, NF-κB, STAT3 and ERK1/2 was found in
HCC, and this was associated with tumor cell survival,
proliferation, invasiveness and metastasis [43-46]. In our
previous study we also found that insufficient RFA acti-
vated the p-Akt/HIF-1α/VEGFA signal pathway of hepa-
toma cells promoting angiogenesis in residual HCC [9].
Our present study revealed that insufficient RFA could
up-regulate the expression of p-ERK1/2, p-Akt and NF-
κB and down-regulate the expression of p-STAT3 in
TAECs. The up-regulated expression of p-ERK1/2, p-
Akt and NF-κB may explain the phenomenon as
described above. However, in the present study, we
could not identify which signal pathway played a key
role in the promotion of rapid growth and metastasis in
residual HCC by TAECs, and why the expression of p-
STAT3 in TAECs was down-regulated after insufficient
RFA. Further study is needed in the future to clarify the
exact mechanism involved in the signal pathway asso-
ciated with the biological behavior of TAECs after insuf-
ficient RFA.
Combined with the findings from our previous re-
search, our present results suggest that insufficient RFA
affects not only hepatoma cells but also TAECs within
the HCC. Such effects should be taken into account in
the treatment of HCC using RFA. Anti-angiogenesis
drugs, which are used to target TAECs, may be useful in
preventing the rapid growth and metastasis of residual
HCC after insufficient RFA.
Conclusions
Enhanced TAEC migration and tube formation after in-
sufficient RFA may play a key role in the rapid growth of
residual HCC. Increased expression of metastasis-related
Kong et al. Journal of Translational Medicine 2012, 10:230 Page 10 of 11
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sible mechanism for the metastasis of residual HCC.
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Additional file 1: Figure S1. Increased TAEC interaction with HCCLM3-
GFP cells after insufficient RFA. (A-B) TAECs were cultured after
insufficient RFA, and HCCLM3-GFP cells were added after 24, 48 and 72 h.
Representative micrographs of TAECs regarding the interaction with
HCCLM3-GFP cells are shown. Columns: means from three individual
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Additional file 2: Figure S2. Promotion of the invasiveness of HCCLM3-
GFP cells by TAECs after insufficient RFA. HCCLM3-GFP invasion in vitro in
response to conditioned media from TAECs was assayed after the control
treatment or insufficient RFA. Representative micrographs of HCCLM3-
GFP cell invasion are shown. Data are the representative results of three
independent experiments with five samples per group.
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